Q&A: Eileen O’Reilly on Pancreatic Cancer

Eileen M. O'Reilly, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York, NY, whose research focuses on therapies for pancreas cancer, spoke with Cancer Discovery's Suzanne Rose about daraxonrasib combinations, treatment strategies under development, the need for genomic testing, and what big headlines might come in pancreas cancer.

Publication Details

Journal
Cancer Discovery
Published
2026-09-28
DOI
https://doi.org/10.1158/2159-8290.cd-nw2026-0092
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Q&A: Eileen O’Reilly on Pancreatic Cancer

Cancer Discovery
Pancreatic and Hepatic Oncology Research
article

Q&A: Eileen O’Reilly on Pancreatic Cancer

article en

Abstract

Eileen M. O'Reilly, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center in New York, NY, whose research focuses on therapies for pancreas cancer, spoke with Cancer Discovery's Suzanne Rose about daraxonrasib combinations, treatment strategies under development, the need for genomic testing, and what big headlines might come in pancreas cancer.

Cancer Discovery
Good health and well-being
Openalex Percentile: Top 15%
Pancreatic and Hepatic Oncology Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Q&A: Eileen O’Reilly on Pancreatic Cancer · Cancer Discovery (2026) | TGRS Research Map | TGRS